| Christopher Ryan Ramos, | |
|
1721 E Manning Ave, Reedley, CA 93654-9468 | |
| (559) 638-6349 | |
| Not Available |
| Full Name | Christopher Ryan Ramos |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1721 E Manning Ave, Reedley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932700655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 83630 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Ryan Ramos, 8885 S Milton Ave, Parlier, CA 93648-2120 Ph: (559) 316-9424 | Christopher Ryan Ramos, 1721 E Manning Ave, Reedley, CA 93654-9468 Ph: (559) 638-6349 |
News Archive
One of the defining characteristics of solid tumors is the development of a network of new blood vessels to nourish the rapidly reproducing malignant cells. Now, using a nanoparticle targeted to those new blood vessels, a joint academic-industrial research team, led by investigators from the Siteman Center of Cancer Nanotechnology Excellence, has developed a way to construct a three-dimensional (3-D) map of tumor-induced angiogenesis and monitor the effects of drug therapies on those new blood vessels.
PolyMedix, Inc. an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, announced that data from two separate pre-clinical research studies were published in the December issue of Molecular Oral Microbiology.
Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were supposed to prevent.
An early-stage clinical trial is evaluating two licensed seasonal influenza vaccines, administered with or without novel adjuvants, for their safety and ability to generate an immune response.
A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2019 Annual Meeting.
› Verified 5 days ago
Dr. Nicole N Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Manning Ave, Reedley, CA 93654 Phone: 559-638-6349 | |
Sue Soojeong Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 852 E Manning Ave, Reedley, CA 93654 Phone: 559-643-0367 | |
Dr. Kionn Alls, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 852 E Manning Ave, Reedley, CA 93654 Phone: 559-643-0367 | |
An Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Manning Ave, Reedley, CA 93654 Phone: 559-638-6349 | |
Gurminder Singh Dhami, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1790 E Manning Ave, Reedley, CA 93654 Phone: 559-643-2790 | |
Ilana Shekoohinia, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1721 E Manning Ave, Reedley, CA 93654 Phone: 559-638-6349 | |
Youn Joong Suh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1065 W Manning Ave, Reedley, CA 93654 Phone: 559-638-0467 |